Other meningitis

G6_MENINGOTH

infectious meningitis: Inflammation of the meninges of the brain and/or spinal cord caused by an infectious agent (viral, bacterial, or fungal). Symptoms include headache, fever, vomiting, neck stiffness, photophobia, confusion, and seizures.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

581

4. Check minimum number of events

None

581

5. Include endpoints

None

581

6. Filter based on genotype QC (FinnGen only)

581

Control definitions (FinnGen only)

Control exclude
G6_NEUINFL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4841 2409 2393
Only index persons 4163 2151 2012
Unadjusted period prevalence (%)
Whole population 0.07 0.07 0.07
Only index persons 0.08 0.08 0.08
Median age at first event (years)
Whole population 40.27 41.58 38.59
Only index persons 37.69 39.51 35.74

-FinnGen-

Key figures

All Female Male
Number of individuals 581 367 214
Unadjusted period prevalence (%) 0.11 0.13 0.09
Median age at first event (years) 43.35 42.06 45.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
516
Matched controls
5158
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G03.9
ICD-10 Finland
Meningitis, unspecified
+∞
323.0
361
*
3229X
ICD-9 Finland
Meningitis of unspecified cause, Meningitis, unspecified
+∞
84.8
79
*
A87.9
ICD-10 Finland
Viral meningitis, unspecified
99.0
83.2
90
11
TAB00
NOMESCO Finland
Lumbar puncture
16.8
74.7
124
95
R51.80
ICD-10 Finland
Headache
4.9
42.5
163
444
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.2
41.9
110
188
G03.0
ICD-10 Finland
Nonpyogenic meningitis
+∞
40.1
38
*
AA1AD
NOMESCO Finland
CT of head and brain
4.1
38.0
179
587
G03.8
ICD-10 Finland
Meningitis due to other specified causes
+∞
36.9
35
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
+∞
32.6
31
*
G03.1
ICD-10 Finland
Chronic meningitis
+∞
29.5
28
*
A86
ICD-10 Finland
Unspecified viral encephalitis
109.3
19.7
21
*
R50.9
ICD-10 Finland
Fever, unspecified
3.2
19.7
116
426
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
18.9
18
*
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
18.9
18
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
17.1
225
1302
G03.2
ICD-10 Finland
Benign recurrent meningitis [Mollaret]
+∞
16.8
16
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
49.2
16.1
19
*
AAF00
NOMESCO Finland
Ventriculostomy
87.8
15.7
17
*
0499X
ICD-9 Finland
Other non-arthropod-borne viral diseases of central nervous system, Unspecified non-arthropod-borne viral diseases of central nervous system
164.8
15.6
16
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
17.1
14.9
23
14
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.4
14.8
35
50
H02AB06
ATC
prednisolone; systemic
2.0
13.6
250
1624
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
13.6
86
328
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.4
13.4
67
216
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
13.1
123
588
N03AX14
ATC
levetiracetam; systemic
7.9
12.6
28
37
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
16.9
11.7
18
11
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
66.5
11.7
13
*
R51
ICD-10 Finland
Headache
4.0
11.6
47
127
L04AX01
ATC
azathioprine; systemic
4.7
11.5
39
89
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
122.6
11.5
12
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
11.1
212
1363
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
11.1
97
443
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.2
11.0
41
103
H47.1
ICD-10 Finland
Papilloedema, unspecified
28.7
10.8
14
5
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
10.7
77
317
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
61.3
10.7
12
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
10.7
36
82
N71
ICPC
Meningitis/encephalitis
112.2
10.5
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
10.4
149
850
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
33.3
10.4
13
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
9.9
10.3
20
21
G91.0
ICD-10 Finland
Communicating hydrocephalus
23.9
10.3
14
6
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
10.1
67
263
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
15.0
10.1
16
11
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
9.8
56
199
H02AB07
ATC
prednisone; oral
2.5
9.6
81
362
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
9.6
88
411
XA800
NOMESCO Finland
Neuropsychological investigation
4.4
9.6
34
82
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
9.5
85
392
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
101.8
9.4
10
*
G00.1
ICD-10 Finland
Pneumococcal meningitis
+∞
9.4
9
*
A87.8
ICD-10 Finland
Other viral meningitis
+∞
9.4
9
*
N03AX16
ATC
pregabalin; oral
2.1
9.4
123
676
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
8.9
9.4
19
22
R42
ICD-10 Finland
Dizziness and giddiness
2.1
9.3
111
585
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.0
9.2
20
26
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
9.2
189
1227
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
15.9
9.1
14
9
G51.0
ICD-10 Finland
Bell palsy
5.8
8.9
24
43
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
7.1
8.6
20
29
ZXC95
NOMESCO Finland
Use of surgical navigator
9.2
8.6
17
19
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
28.0
8.5
11
*
5AB01
NOMESCO Finland
NA
91.5
8.4
9
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.6
8.4
28
64
N06AA09
ATC
amitriptyline; systemic
2.7
8.4
56
220
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
8.4
8
*
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
8.4
8
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
8.4
8
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
33.9
8.1
10
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
9.1
8.1
16
18
WX882
NOMESCO Finland
High dependency care
4.7
8.0
26
58
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
8.0
83
412
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
7.9
54
216
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.0
7.9
24
50
SPAT1255
SPAT
Intravenous administration of medicine
3.2
7.8
39
127
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
7.8
75
360
P01BA02
ATC
hydroxychloroquine; oral
2.9
7.7
48
179
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
7.7
39
129
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
81.2
7.4
8
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
81.2
7.4
8
*
G02.0
ICD-10 Finland
Meningitis in viral diseases classified elsewhere
81.2
7.4
8
*
ABE50
NOMESCO Finland
Occipitocervical decompression
+∞
7.3
7
*
J01EA01
ATC
trimethoprim; systemic
1.9
7.2
130
794
N03AX12
ATC
gabapentin; oral
2.1
7.2
81
413
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
7.2
34
107
G44.2
ICD-10 Finland
Tension-type headache
2.2
7.1
77
388
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
7.1
65
302
G43.9
ICD-10 Finland
Migraine, unspecified
2.9
7.1
41
148
J05AB11
ATC
valaciclovir; oral
2.1
7.0
78
396
N01
ICPC
Headache
2.3
7.0
67
320
H53.2
ICD-10 Finland
Diplopia
4.8
6.8
21
45
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
40.6
6.8
8
*
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.3
6.7
15
21
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
7.3
6.7
15
21
AA1AA
NOMESCO Finland
Head X-ray examination
22.9
6.7
9
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
6.7
93
518
M01AE02
ATC
naproxen; oral, rectal
1.6
6.6
285
2235
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.4
6.6
53
232
H02AB09
ATC
hydrocortisone; systemic
4.6
6.5
21
47
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
6.5
37
131
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
6.4
48
203
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
8.3
6.4
13
16
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
11.2
6.3
11
10
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.9
6.3
19
40
B34.9
ICD-10 Finland
Viral infection, unspecified
3.9
6.3
24
64
G00.2
ICD-10 Finland
Streptococcal meningitis
+∞
6.3
6
*
G44.8
ICD-10 Finland
Other specified headache syndromes
7.2
6.3
14
20
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.2
144
949
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.1
6.2
18
36
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
6.2
57
264
N02BE01
ATC
paracetamol; systemic, rectal
1.7
6.2
417
3647
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
6.1
158
1075
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.1
181
1278
ZX120
NOMESCO Finland
Intravenous
2.4
6.0
49
217

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
144
37
51.37
242.54
2.3
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
173
118
20.44
203.16
2.2
1.2
mg/l
908.4
441.4
6.78
167
110
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
166
105
21.71
202.29
2.0
1.1
mmol/l
3.3
3.8
3.28
158
97
(3044290) Cell count panel - Cerebral spinal fluid
153
94
21.72
188.52
2.2
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
142
109
16.90
154.85
2.1
1.2
e6/l
1431.7
1124.8
0.11
119
89
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
142
109
16.90
154.85
2.0
1.2
e6/l
376.3
5.1
2.34
118
84
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
86
20
50.25
146.45
1.4
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
79
15
60.75
140.21
2.3
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
93
38
28.92
134.36
2.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
83
25
38.53
132.10
1.4
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
19
32.48
85.33
1.3
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
70
45
17.53
82.42
1.1
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
50
17
32.06
75.98
1.2
1.1
ng/l
275.0
—
—
24
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
45
12
40.53
73.20
1.3
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
44
12
39.55
71.12
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
43
12
38.58
69.05
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
44
17
27.90
63.92
1.3
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
38
12
33.78
58.78
1.3
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
56
51
12.03
53.56
1.8
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
127
297
5.19
52.56
1.6
1.3
au/ml
48.2
34.5
—
5
14
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
34
12
30.01
50.69
1.4
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
130
334
4.72
47.76
2.9
2.4
au/ml
43.1
16.2
—
7
12
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
37
20
19.67
46.84
1.1
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
250
1085
3.29
42.00
4.8
4.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
40
40
10.66
35.71
1.7
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
35
29
12.77
35.28
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
7
51.38
28.70
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
33
40
8.68
25.45
1.3
1.1
mg/l
60.7
30.7
1.95
26
30
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
29
31
9.79
24.57
1.2
1.1
u/l
1.3
1.1
0.55
17
17
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
152
664
2.74
23.13
2.0
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
29
34
8.92
22.92
1.8
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
29
35
8.66
22.41
1.1
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
27
8
35.27
21.28
1.3
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
31
46
7.06
20.13
2.3
2.0
e9/l
1.6
1.0
1.11
16
21
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
53
131
4.35
19.86
1.5
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
325
2112
2.22
19.47
8.6
6.5
mmol/l
1.2
1.2
1.19
281
1780
(21494814) CD8 cells/100 lymphocytes in Specimen
17
11
15.88
19.40
1.9
1.9
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
28
39
7.49
19.21
1.1
1.1
mg/l
332.5
215.3
1.34
21
34
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
37
70
5.57
18.94
1.2
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
27
37
7.60
18.78
2.0
2.1
%
43.0
43.5
—
5
6
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
6
39.80
18.67
1.1
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
24
9.48
18.29
1.4
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
270
1663
2.16
18.13
7.8
7.5
inr
1.2
1.2
0.43
72
522
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
114
4.39
18.02
2.2
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
342
2339
2.12
17.11
7.2
6.0
umol/l
10.7
10.7
0.00
329
2216
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
32
7.77
17.06
1.9
2.0
%
10.6
12.6
—
7
19
(42870588) Differential panel, method unspecified - Blood
252
1539
2.12
17.01
8.2
5.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
369
2609
2.13
16.76
5.9
4.6
mmol/l
6.5
6.6
0.14
354
2411
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
293
1917
2.06
16.22
8.3
5.8
mmol/l
1.2
1.2
0.99
279
1752
(4027681)
24
35
7.10
15.79
1.4
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
51
146
3.73
15.61
2.1
1.8
ug/l
1.2
3.3
0.52
46
129
(4062490)
26
45
6.00
14.56
1.6
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
126
617
2.33
14.41
1.8
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
33
72
4.79
14.39
1.4
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
19
7
27.96
14.35
1.1
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
19
7
27.96
14.35
1.1
1.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
326
2285
1.97
14.15
8.9
5.9
%
28.3
28.6
0.16
305
2141
(3001604) Monocytes [#/volume] in Blood
331
2338
1.96
13.99
8.5
5.9
e9/l
0.6
0.6
0.46
293
2034
(3024980) IgG subclass 4 [Mass/volume] in Serum
33
74
4.66
13.93
1.9
1.5
g/l
0.6
0.6
0.01
26
57
(3024561) Albumin [Mass/volume] in Serum or Plasma
273
1813
1.95
13.78
5.8
4.6
g/l
35.5
36.2
0.90
259
1697
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
31
6.98
13.65
2.1
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
369
2718
1.98
13.63
11.0
8.9
e9/l
4.3
4.0
1.24
333
2376
(3006315) Basophils [#/volume] in Blood
331
2352
1.94
13.59
8.5
5.9
e9/l
0.0
0.0
0.05
293
2045
(3013115) Eosinophils [#/volume] in Blood
339
2434
1.94
13.42
8.8
6.2
e9/l
0.2
0.2
0.47
298
2157
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
10
13.26
13.39
1.0
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
314
2202
1.92
13.31
8.9
5.9
%
2.8
2.8
0.01
298
2050
(3019198) Lymphocytes [#/volume] in Blood
337
2420
1.93
13.28
8.5
5.8
e9/l
2.2
2.0
0.39
302
2154
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
30
65
4.81
13.18
1.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
99
452
2.43
13.18
2.0
1.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
39
6.09
13.13
2.2
2.1
e6/l
658.8
695.7
0.09
14
16
(3003396) Base excess in Arterial blood by calculation
94
420
2.47
13.11
8.5
8.8
mmol/l
0.8
1.3
0.51
72
332
(3022096) Basophils/100 leukocytes in Blood
305
2126
1.91
13.09
9.0
6.0
%
0.6
0.7
1.18
287
1980
(3018010) Neutrophils/100 leukocytes in Blood
319
2260
1.91
12.99
8.4
5.7
%
57.0
56.9
0.06
300
2121
(3019069) Monocytes/100 leukocytes in Blood
314
2214
1.91
12.96
9.3
6.2
%
8.4
8.4
0.02
297
2080
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
27
7.23
12.75
1.4
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
75
306
2.66
12.60
2.2
1.7
g/l
1.7
1.4
0.23
68
283
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
43
127
3.57
12.57
1.6
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
49
159
3.27
12.38
2.3
1.7
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
45
5.52
12.38
1.6
1.2
g/l
0.3
0.4
0.52
18
29
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
45
5.52
12.38
1.6
1.2
g/l
5.6
6.6
0.88
18
29
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
45
5.52
12.38
1.6
1.2
g/l
2.6
2.6
0.09
18
28
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
221
1405
1.92
12.37
2.7
2.4
u/l
48.7
55.3
3.64
210
1303
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
98
458
2.37
12.35
2.0
1.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
16
6
27.33
12.09
1.4
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
56
201
2.97
11.94
1.8
2.1
u/l
37.7
40.7
0.59
50
182
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
244
1619
1.87
11.85
3.4
3.3
ng/l
21.7
58.8
0.91
152
1022
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
436
3494
1.99
11.50
10.4
7.2
u/l
76.9
77.7
0.16
427
3276
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
304
2.52
10.78
1.8
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
27
64
4.37
10.65
1.3
1.3
mmol/l
68.6
59.7
0.36
22
56
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
17
8.41
10.64
2.4
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
48
170
2.99
10.47
1.9
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
385
3007
1.83
10.44
7.0
4.2
e6/l
7700.6
1591.2
—
8
47
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
10
11.18
10.18
2.3
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
56
223
2.67
9.84
1.7
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
86
423
2.21
9.52
3.2
4.4
u/l
232.5
259.9
0.69
81
404
(3012095) Magnesium [Moles/volume] in Serum or Plasma
121
678
1.99
9.49
4.7
3.7
mmol/l
0.8
0.8
0.42
115
639
(3002032) Base excess in Venous blood by calculation
77
369
2.25
9.06
3.9
3.6
mmol/l
1.6
1.9
0.39
68
291
(3013247) Albumin in CSF/Albumin in Serum or Plasma
11
12
9.32
8.99
1.2
1.0
mg/g
8.1
5.5
0.41
11
12
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
59
254
2.47
8.84
1.5
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
198
1322
1.75
8.84
4.0
2.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
226
1570
1.72
8.73
4.7
3.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
57
244
2.48
8.65
8.3
6.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
13
8.60
8.48
1.2
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
19
6.97
8.46
1.8
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
42
158
2.78
8.24
3.8
2.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
114
3.10
8.16
1.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
110
3.12
8.00
1.6
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
90
3.34
7.89
6.1
5.9
iu/ml
763.8
443.7
—
5
14
(3037467) Urinalysis macro (dipstick) panel - Urine
393
3210
1.69
7.86
6.8
4.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
21
6.30
7.73
1.3
1.1
miu/ml
1293.8
1838.8
0.77
13
21
(3007853) Bacteria identified in Skin by Aerobe culture
95
525
1.97
7.66
2.0
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
47
195
2.53
7.62
9.8
12.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
12
8.45
7.59
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
112
657
1.87
7.55
1.4
1.4
titre
726.9
505.1
0.43
29
150
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
117
2.93
7.22
1.3
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
33
118
2.90
7.11
8.1
10.5
mmol/l
1.2
1.2
0.01
28
100
(3000991) Gas panel - Venous blood
65
321
2.15
7.09
7.4
8.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
159
1052
1.70
7.09
1.9
1.7
mg/l
1.4
1.1
0.58
118
787
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
93
3.11
6.85
4.1
3.8
e9/l
3.7
4.2
0.43
28
93
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
126
792
1.75
6.72
3.7
3.5
ng/l
128.1
293.7
0.82
82
569
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
95
3.04
6.62
5.0
4.2
%
53.3
57.2
0.62
28
95
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
33
4.64
6.48
1.3
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
294
2300
1.56
6.46
7.2
4.7
estimate
0.0
0.0
0.00
56
457
(3044640) Blood type and Crossmatch panel - Blood
197
1411
1.60
6.32
2.8
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
121
2.74
6.25
2.9
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
142
941
1.67
6.20
4.3
2.4
e6/l
7.5
6.2
0.29
133
822
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
277
2152
1.55
6.19
4.4
3.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
22
67
3.37
6.19
1.3
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
26
89
3.01
6.06
1.3
1.1
—
10.8
—
0
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
133
871
1.68
6.06
1.6
1.7
pmol/l
115200442.8
42683365.4
0.27
125
738
(3022217) INR in Platelet poor plasma by Coagulation assay
85
489
1.86
6.04
18.5
18.2
inr
1.3
1.2
0.11
12
76
(36304419) Bacteria [Presence] in Urine
171
1199
1.60
5.93
4.5
2.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
6
15.19
5.91
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
294
2332
1.53
5.86
5.4
3.5
estimate
0.0
0.0
0.50
55
439
(3023183) Ammonium ion [Moles/volume] in Plasma
26
91
2.94
5.84
2.2
4.2
umol/l
33.0
36.6
0.39
26
75
(3026782) Osmolality of Urine
136
905
1.65
5.81
4.1
2.5
mosm/kgh2o
505.0
562.3
2.08
125
771
(3013707) Erythrocyte sedimentation rate by Westergren method
405
3449
1.57
5.78
5.8
3.9
mm/h
12.4
10.6
1.98
392
3189
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
82
3.01
5.63
1.5
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
155
1075
1.60
5.58
2.8
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
33
4.32
5.58
1.8
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
246
1896
1.51
5.51
3.0
2.3
nmol/l
75.5
75.2
0.07
233
1709
(3035637) Corticotropin [Mass/volume] in Plasma
18
52
3.54
5.48
1.3
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
69
384
1.90
5.43
4.9
4.5
%
1.0
0.9
0.03
24
112
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
210
1569
1.53
5.43
3.6
3.3
u/l
32.9
31.2
0.42
203
1497
(3030467) Casts [#/volume] in Urine by Automated count
170
1212
1.57
5.43
4.7
2.9
e6/l
0.3
0.4
0.34
134
914
(3002179) Metamyelocytes/100 leukocytes in Blood
64
348
1.94
5.39
4.6
4.4
%
0.6
0.4
0.60
20
75
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
110
707
1.68
5.34
3.3
2.6
e6/l
1.7
1.0
0.52
64
387
(3006653) Thiamine [Moles/volume] in Blood
10
18
5.63
5.33
1.3
1.4
nmol/l
120.6
142.6
—
10
18
(40758558) Short blood count panel - Blood
165
1176
1.56
5.25
6.9
6.6
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
286
2293
1.48
5.19
5.4
3.4
estimate
0.0
0.0
0.00
54
444
(3002582) Erythrocytes [#/volume] in Urine
184
1348
1.53
5.16
5.0
3.0
e6/l
29.0
100.2
0.83
155
1043
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
140
2.44
5.15
1.7
1.6
iu/ml
0.0
0.0
—
5
24
(44790047)
18
55
3.34
5.06
1.1
1.4
—
—
—
0
0
(44790049)
18
55
3.34
5.06
1.1
1.4
—
—
—
0
0
(44806118)
18
55
3.34
5.06
1.1
1.4
—
—
—
0
0
(44790048)
18
55
3.34
5.06
1.1
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
269
2.02
5.05
6.6
3.8
mmol/l
0.9
1.5
0.58
41
192
(3017732) Neutrophils [#/volume] in Blood
59
320
1.94
5.01
2.9
2.4
e9/l
4.0
4.0
0.03
42
261
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
36
3.96
5.00
1.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
36
3.96
5.00
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
36
3.96
5.00
1.1
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
36
3.96
5.00
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
175
1277
1.53
4.97
5.3
3.8
ph
7.4
7.4
0.51
41
247
(3025159) Blasts/100 leukocytes in Blood
62
344
1.90
4.93
5.0
4.7
%
0.1
0.0
0.50
22
82
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
217
1659
1.49
4.92
2.1
1.9
pmol/l
102.2
95.3
1.01
119
858
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
101
2.65
4.86
4.2
2.4
u/ml
0.4
0.4
0.33
15
59
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
7
11.55
4.79
1.5
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
210
1603
1.48
4.77
5.7
3.5
e6/l
67.6
110.0
0.60
164
1126
(3022621) pH of Urine by Test strip
53
282
1.97
4.76
2.6
2.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
43
215
2.08
4.58
6.9
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
142
2.32
4.55
1.1
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.82
4.54
1.1
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.82
4.54
1.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.82
4.54
1.1
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.82
4.54
1.1
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
87
2.71
4.53
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
87
2.71
4.53
1.4
1.4
—
—
—
0
0
(4035726)
64
370
1.82
4.48
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
33
150
2.27
4.45
7.9
4.2
—
—
—
0
0
(3009343) pH of Capillary blood
52
282
1.93
4.43
7.3
3.8
ph
7.4
7.4
—
5
35
(3021440) Promyelocytes/100 leukocytes in Blood
62
357
1.82
4.40
5.2
4.7
%
0.3
0.2
0.16
22
99
(3015377) Calcium [Moles/volume] in Serum or Plasma
190
1441
1.47
4.39
3.4
3.0
mmol/l
2.3
2.4
0.41
168
1284
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
35
3.77
4.38
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
110
742
1.59
4.37
1.8
1.7
nmol/l
1313.6
1180.6
0.74
93
552
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
380
3281
1.45
4.35
4.3
3.1
u/l
55.2
42.0
1.49
371
3102
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
231
1821
1.44
4.35
5.5
3.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
9
8.98
4.29
1.6
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
56
3.09
4.26
2.5
2.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
51
3.20
4.23
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
143
1036
1.50
4.11
4.7
3.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
56
320
1.83
4.08
2.1
2.3
ug/l
4.7
6.8
0.79
48
284
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
42
3.39
4.06
1.1
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
38
191
2.06
4.02
2.5
2.5
%
0.7
0.7
0.21
38
186
(3023520) Reticulocytes [#/volume] in Blood
52
293
1.85
3.97
2.2
2.8
e9/l
69.5
71.4
0.19
40
222
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
515
4772
1.69
3.95
22.9
12.4
mg/l
23.2
21.4
0.62
466
3682
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
100
676
1.58
3.93
3.5
2.8
e6/l
2.6
2.7
0.06
56
360
(3019225) pH of Specimen
64
388
1.73
3.83
5.0
3.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
28
131
2.19
3.56
3.4
3.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
81
2.52
3.49
1.7
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
147
1105
1.44
3.45
2.0
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
148
1116
1.44
3.41
2.8
2.6
umol/l
337.5
6838.8
4.37
142
969
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
82
2.49
3.41
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
70
2.62
3.40
1.5
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
76
2.55
3.40
2.1
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
27
127
2.18
3.40
1.6
1.3
u/ml
10.1
2.6
—
5
18
(3025941) Bacteria identified in Stool by Culture
49
285
1.78
3.40
1.3
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
14
5.77
3.35
1.1
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
14
5.77
3.35
1.1
2.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
14
5.77
3.35
1.4
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
27
128
2.16
3.34
1.6
1.3
u/ml
8.6
12.4
—
9
26
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
83
2.46
3.33
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
83
2.46
3.33
1.4
1.2
u/ml
2.5
4.2
—
8
29
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
83
2.46
3.33
1.5
1.2
u/ml
13.3
4.3
—
8
36
(3019550) Sodium [Moles/volume] in Serum or Plasma
509
4744
1.58
3.31
23.6
13.8
mmol/l
139.3
139.7
2.22
504
4618
(3019832) Treponema pallidum Ab [Presence] in Serum
93
643
1.53
3.30
1.4
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
145
1096
1.43
3.29
3.0
3.1
ng/l
848.1
1023.5
0.51
118
913
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
54
2.82
3.27
1.5
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
7
8.64
3.27
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
84
2.43
3.25
1.9
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
87
595
1.54
3.24
2.9
2.2
g/l
2.3
2.4
0.10
81
547
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
15
5.39
3.20
1.1
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
146
1111
1.42
3.18
6.8
4.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
161
1248
1.40
3.16
6.2
3.7
estimate
0.0
0.0
0.69
52
446
(3023103) Potassium [Moles/volume] in Serum or Plasma
509
4757
1.56
3.11
23.4
13.9
mmol/l
3.9
4.0
0.35
504
4620
(40760888) Immunoglobulin light chains.free panel - Serum
20
86
2.37
3.10
2.1
4.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
75
501
1.57
3.10
6.5
6.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
39
3.12
3.10
1.5
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
12
5.88
3.02
3.0
1.7
—
—
—
0
0
(4306422)
18
75
2.44
2.99
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
40
3.04
2.98
1.5
1.3
—
—
—
0
0
(3010421) pH of Blood
24
114
2.15
2.98
5.0
2.9
ph
7.4
7.4
0.60
19
97
(3045414) Leukocytes [Presence] in Urine
35
193
1.86
2.90
1.4
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
17
70
2.47
2.90
1.9
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
65
427
1.59
2.89
2.5
2.9
%
1.7
1.8
0.17
58
379
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
48
293
1.69
2.85
2.3
3.0
ng/l
178.3
163.9
0.10
43
259
(1761868) Lipid panel - Serum or Plasma
144
1814
0.72
2.82
2.6
2.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
20
90
2.26
2.82
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
20
90
2.26
2.82
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
53
2.68
2.81
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
53
2.68
2.81
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
135
1035
1.40
2.80
5.1
3.6
kg/l
1.0
1.0
1.09
23
147
(3041096) Erythrocytes [Presence] in Urine by Automated
168
1336
1.36
2.78
5.3
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
42
2.89
2.76
2.9
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
127
966
1.40
2.75
1.7
1.5
nmol/l
23.2
21.0
0.80
108
817
(3007164) IgA [Mass/volume] in Serum or Plasma
137
1056
1.39
2.74
1.8
1.4
g/l
2.2
2.3
0.27
102
672
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
182
1.86
2.74
1.5
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
21
98
2.18
2.73
5.4
3.0
mmol/l
2.4
2.5
—
9
63
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
60
2.54
2.71
1.6
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
54
2.63
2.71
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
54
2.63
2.71
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
54
2.63
2.71
1.5
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
10
6.04
2.70
1.3
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
44
267
1.70
2.68
2.4
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
99
2.16
2.67
2.1
2.1
g/l
124.2
131.5
0.42
12
75
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
99
2.16
2.67
2.1
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
43
2.83
2.65
3.1
2.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
53
339
1.62
2.64
4.3
3.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
149
1.92
2.60
2.1
2.1
g/l
7.5
7.4
0.07
19
116
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
149
1.92
2.60
2.1
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
149
1.92
2.60
2.1
2.1
g/l
3.8
3.7
0.07
17
111
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
20
4.04
2.57
1.3
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
20
4.04
2.57
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
86
618
1.46
2.54
1.6
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
27
3.37
2.40
1.7
2.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
77
2.24
2.39
1.3
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
104
2.06
2.38
1.5
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
169
1.82
2.36
1.6
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
42
261
1.66
2.36
1.6
1.3
iu/l
26.6
25.5
0.07
36
219
(3011648) Oxygen content in Venous blood
9
28
3.25
2.31
2.1
1.6
%
10.3
11.2
—
9
28
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
35
2.89
2.31
1.6
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
77
553
1.45
2.29
3.2
2.3
%
22.1
23.4
0.27
64
480
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
92
2.10
2.29
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
92
2.10
2.29
1.7
2.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
13
4.65
2.27
1.2
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
18
3.92
2.25
1.1
1.4
—
—
—
0
0
(3036489) Thrombin time
31
180
1.76
2.23
2.5
1.9
s
20.6
21.4
0.51
25
163
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
100
2.03
2.23
1.6
1.4
u/ml
233.5
238.0
0.04
13
60
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
54
2.44
2.21
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
99
750
1.38
2.19
3.2
2.6
mmol/l
2.4
2.4
0.01
86
660
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
19
3.71
2.15
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
19
3.71
2.15
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
74
535
1.44
2.13
3.0
2.8
umol/l
8.8
8.0
0.11
62
463
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
13
55
2.39
2.13
1.2
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
471
4415
1.35
2.11
16.7
11.3
ml/min/173m2
87.2
85.9
0.61
412
3609
(3051651) Icteric interference index of Serum or Plasma
9
31
2.93
2.07
3.0
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
396
3630
1.28
2.07
4.9
4.0
pmol/l
14.8
14.6
0.73
371
3317
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
140
1.82
2.03
1.5
2.1
g/l
3.1
3.1
0.10
18
112
(4034850)
25
140
1.82
2.03
4.3
9.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
134
1076
1.32
2.03
2.4
2.1
mg/l
3.1
3.0
0.13
119
923
(40767503) Oxygen content in Capillary blood by calculation
17
83
2.08
2.02
3.1
2.3
%
15.3
16.5
—
8
42
(3022948) Iron [Moles/volume] in Serum or Plasma
87
654
1.39
2.02
3.1
2.3
umol/l
12.3
13.6
1.21
82
592
(4198724)
8
26
3.10
2.02
1.0
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
343
3098
1.26
1.99
3.7
3.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
(3013512) EKG study
147
1203
1.30
1.93
3.7
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
78
2.08
1.92
1.3
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
526
5038
1.46
1.91
14.5
9.6
u/l
28.3
26.2
1.99
518
4890
(3010375) cycloSPORINE [Mass/volume] in Blood
7
22
3.20
1.88
42.0
33.0
ug/l
91.9
112.5
—
7
17
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
28
2.88
1.86
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
69
509
1.40
1.80
4.3
4.1
%
32.9
31.6
0.40
50
337
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
67
2.11
1.77
2.1
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
18
3.35
1.75
1.2
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
18
3.35
1.75
2.3
1.7
ug/l
123.0
58.0
—
6
18
(3004616) Nuclear Ab [Presence] in Serum
12
54
2.25
1.74
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
210
1.60
1.74
3.8
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
104
825
1.32
1.72
1.3
1.3
iu/ml
42.0
29.4
0.37
36
254
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
101
801
1.31
1.67
1.2
1.3
u/ml
11.1
11.8
0.04
37
324
(1616796) Gas panel - Central venous blood
18
98
1.86
1.63
4.8
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
373
3441
1.23
1.63
3.5
3.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
14
3.59
1.61
1.2
3.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
157
1327
1.25
1.57
3.4
3.0
mmol/l
7.5
7.8
0.31
139
1117
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
59
435
1.40
1.56
2.2
2.2
u/l
28.4
30.0
0.26
51
369
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
443
4173
1.26
1.55
5.7
5.3
mmol/mol
39.5
39.3
0.10
419
3912
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
33
2.44
1.54
1.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
25
154
1.65
1.52
3.4
3.4
g/l
0.2
0.2
0.00
11
61
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
101
1.81
1.50
1.5
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
422
1.39
1.48
3.5
3.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
38
2.39
1.46
2.4
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
44
312
1.44
1.45
5.5
3.6
ng/l
87.3
75.2
0.53
39
279
(4268621)
11
52
2.14
1.45
2.5
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
519
4999
1.35
1.44
20.3
11.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
39
2.33
1.43
2.6
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
182
1.56
1.39
2.1
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
29
2.43
1.39
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
67
1.96
1.39
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
160
1.59
1.33
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
72
564
1.31
1.32
1.8
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
83
1.83
1.32
1.1
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
24
2.51
1.30
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
161
1.58
1.30
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
236
2114
1.19
1.30
12.6
8.8
e9/l
0.0
0.0
0.58
192
1734
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
34
2.37
1.29
1.1
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
136
1157
1.23
1.28
3.2
3.2
mg/l
1016.6
174.7
0.72
88
743
(4146454)
8
35
2.30
1.27
2.5
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
129
1095
1.23
1.24
1.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
56
1.98
1.22
2.4
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
164
1.55
1.22
1.2
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
19
117
1.64
1.19
1.6
2.3
g/l
0.0
0.0
0.34
19
109
(40768804) Tissue Pathology biopsy report
205
1829
1.19
1.16
2.1
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
113
0.44
1.13
2.2
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
339
0.66
1.12
1.5
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
14
81
1.74
1.09
1.6
1.5
nmol/l
0.3
0.4
—
9
66
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
128
1.58
1.09
1.3
1.4
ug/g
225.5
316.0
1.41
11
76
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
66
1.83
1.09
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
350
1.34
1.06
2.2
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
235
2134
1.17
1.06
3.4
2.8
ug/l
113.8
99.4
0.50
222
1982
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
7
33
2.13
1.05
1.9
1.4
u/l
8.3
10.7
—
7
12
(40768797) Stomach Pathology biopsy report
74
603
1.26
1.03
1.1
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
22
2.28
1.03
1.2
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
22
2.28
1.03
1.2
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
105
890
1.22
1.03
1.7
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
7
34
2.07
1.03
1.9
2.7
—
49.4
—
0
10
(3003327) Ova and parasites identified in Stool by Light microscopy
24
163
1.49
1.03
2.0
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
141
1231
1.19
1.01
3.9
4.0
mg/mmol
18.8
9.6
0.66
90
781
(3044941) Cell count panel - Synovial fluid
10
54
1.87
0.97
1.6
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
54
1.87
0.97
1.7
3.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
93
1.63
0.94
1.3
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
144
0.55
0.94
2.0
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
37
1.90
0.94
4.7
3.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
48
601
0.78
0.89
1.3
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
203
1.40
0.88
1.3
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
63
518
1.24
0.84
1.6
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
57
1.77
0.84
1.8
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
57
1.77
0.84
1.0
1.1
g/l
1.4
1.5
—
10
50
(3005570) Glucose [Moles/volume] in Urine
8
46
1.75
0.82
1.5
2.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
105
1.54
0.82
1.6
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
32
1.88
0.82
1.5
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
484
0.77
0.81
1.8
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
86
734
1.20
0.81
1.9
2.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
47
1.71
0.81
2.3
4.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
66
549
1.23
0.80
1.6
1.8
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
78
661
1.21
0.79
1.6
1.8
%
1.5
1.4
0.55
67
589
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.2
—
169.3
—
0
26
(3016750) Collection duration of Urine
0
26
0.00
0.78
0.0
2.0
—
490.9
—
0
16
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
449
4330
1.16
0.77
5.7
4.7
mu/l
1.8
2.1
0.60
423
3999
(3021879) Hepatitis B virus core Ab [Presence] in Serum
49
396
1.26
0.77
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
34
1.77
0.76
1.3
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
83
1.58
0.75
7.5
2.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
55
1.64
0.73
1.3
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
7
38
1.85
0.73
1.9
2.1
mmol/l
6.2
6.5
—
7
29
(4024509)
7
38
1.85
0.73
1.9
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
25
2.01
0.72
1.2
2.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.72
2.4
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
39
309
1.28
0.72
1.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
2.4
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
73
623
1.20
0.70
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
154
1396
1.14
0.69
1.5
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
27
1.86
0.68
1.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
2.4
1.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
15
102
1.48
0.68
2.7
1.9
pmol/l
196.5
230.6
0.54
15
95
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
101
890
1.16
0.67
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
31
241
1.30
0.67
1.2
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
7
43
1.63
0.67
3.4
3.3
mg/l
83.4
20.4
—
7
31
(3048689) Calprotectin [Mass/mass] in Stool
75
645
1.19
0.67
2.7
2.5
ug/g
121.7
116.1
0.08
66
514
(3017446) Testosterone [Moles/volume] in Serum or Plasma
40
322
1.26
0.66
2.7
2.2
nmol/l
10.0
13.6
2.06
32
294
(3023199) Leukocytes [#/volume] in Pleural fluid
5
28
1.79
0.66
1.4
1.4
e6/l
1425.8
1501.8
—
5
16
(3028308) Erythrocytes [#/volume] in Pleural fluid
5
28
1.79
0.66
1.4
1.4
e6/l
37277.4
44005.4
—
5
13
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
29
1.73
0.64
2.6
1.6
%
11.0
39.0
—
5
20
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
638
0.83
0.63
2.7
2.8
ug/l
0.7
0.7
0.07
38
388
(3011288) Drugs identified in Urine by Screen method
23
173
1.34
0.62
1.5
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
353
1.23
0.61
2.9
2.5
ml/min/173m2
70.7
69.7
0.05
18
154
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
30
1.67
0.61
4.0
3.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
50
1.61
0.61
1.8
1.7
pg
32.9
33.1
—
8
50
(3039162) Centromere protein B Ab [Units/volume] in Serum
10
64
1.57
0.58
1.7
1.4
—
62.8
—
0
6
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
319
0.77
0.58
1.1
1.2
—
—
—
0
0
(4094501)
15
106
1.42
0.58
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
35
1.72
0.58
1.8
2.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
54
1.49
0.57
1.4
1.3
nmol/l
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
115
1.40
0.57
1.4
1.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
6
36
1.67
0.57
1.5
1.5
g/l
32.6
31.4
—
6
31
(21494434) Karyotype in Bone marrow
6
36
1.67
0.57
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
26
203
1.29
0.56
1.3
1.3
miu/ml
227.9
236.2
0.04
11
102
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
73
1.52
0.56
1.4
2.6
u/ml
2.8
60.5
0.52
11
67
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
116
1.39
0.54
1.6
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
64
1.41
0.51
1.4
1.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
135
1.34
0.51
1.3
1.9
iu/l
2.3
6.3
—
5
48
(3027944) Amphetamines [Presence] in Urine
32
261
1.24
0.50
1.2
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
24
189
1.28
0.50
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
84
1.44
0.49
7.8
3.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
262
1.23
0.49
1.2
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
32
262
1.23
0.49
1.2
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
15
111
1.36
0.47
1.8
2.3
g/l
0.0
0.0
0.00
15
103
(3028300) Cannabinoids [Presence] in Urine
32
264
1.22
0.46
1.3
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
404
1.18
0.45
7.9
3.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
311
1.20
0.45
1.1
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
306
0.81
0.44
1.1
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
51
443
1.16
0.44
2.6
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
32
1.57
0.42
2.2
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
45
389
1.17
0.41
1.3
1.2
iu/ml
136.7
161.4
0.13
18
163
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
89
808
1.12
0.41
2.1
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
33
1.52
0.41
3.2
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
33
1.52
0.41
2.4
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
0.7
—
0
9
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
34
1.47
0.40
6.6
2.7
%
67.0
102.1
—
5
34
(40768806) Pleura Pathology biopsy report
5
34
1.47
0.40
1.4
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
251
1.20
0.39
2.3
2.3
u/l
918.3
2488.9
0.84
13
111
(3021788) Differential panel - Synovial fluid
8
61
1.31
0.39
1.6
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
35
1.43
0.39
1.2
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
71
1.41
0.39
2.0
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
214
0.79
0.38
2.2
1.9
—
—
—
0
0
(44813793)
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
67
1.35
0.38
1.3
1.8
%
13.2
13.2
—
9
67
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
112
1207
0.91
0.38
1.7
1.6
mmol/l
1.6
1.4
0.90
100
1023
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
90
1.34
0.36
1.0
1.0
u/ml
2.9
0.8
—
7
40
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
78
0.64
0.36
1.2
1.2
u/l
39.1
29.1
—
5
67
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
99
1.32
0.35
6.4
3.7
mg/l
20.6
27.4
—
5
62
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
6
43
1.40
0.35
2.0
1.5
%
53.7
49.6
—
6
31
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
181
1.22
0.34
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
181
1.22
0.34
1.3
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
44
1.37
0.34
1.2
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
182
1.22
0.33
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
182
1.22
0.33
1.3
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
14
110
1.28
0.31
1.9
2.3
g/l
0.0
0.0
0.00
14
103
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
336
0.86
0.31
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
184
1.20
0.30
1.3
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
55
1.27
0.30
4.0
2.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
55
1.27
0.30
4.0
2.5
mmol/l
105.6
105.8
—
7
55
(3041354) Potassium [Moles/volume] in Venous blood
7
55
1.27
0.30
4.0
2.5
mmol/l
4.0
4.0
—
7
55
(3005033) Fetal Nuchal fold Thickness US
18
149
1.21
0.28
1.3
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
63
1.27
0.28
1.4
1.2
nmol/l
0.5
0.5
—
8
56
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
150
1.21
0.26
1.3
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
452
4449
1.07
0.25
4.4
4.2
mmol/l
5.9
5.9
0.03
427
4095
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
26
227
1.15
0.24
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
451
4442
1.06
0.23
3.8
3.7
mmol/l
1.4
1.3
1.97
433
4129
(3050129) First trimester maternal screen panel - Serum or Plasma
25
218
1.15
0.23
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
469
4626
1.07
0.23
4.2
4.1
mmol/l
4.7
4.7
0.35
445
4322
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
401
1.10
0.22
3.6
4.0
ug/l
2.6
17.7
0.79
33
325
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
1.7
—
0
10
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.1
—
1.9
—
0
5
(4133840)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
154
1.17
0.21
1.3
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
90
1.23
0.19
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
475
4696
1.06
0.18
4.7
4.5
mmol/l
2.8
2.8
0.15
448
4356
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
123
1178
1.05
0.18
1.3
1.3
u/ml
1.6
1.4
0.10
32
322
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
175
1.15
0.18
1.6
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
58
1.21
0.18
1.6
1.2
mu/l
66.2
37.3
—
7
52
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
110
1.18
0.17
1.1
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
80
1.13
0.15
1.1
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
150
0.86
0.15
1.7
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
90
862
1.05
0.14
3.7
3.9
%
19.0
21.6
1.13
45
375
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
200
0.90
0.13
1.2
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
465
4609
1.04
0.12
4.2
4.0
mmol/l
1.5
1.5
0.00
440
4282
(40768793) Breast Pathology biopsy report
13
114
1.14
0.11
1.2
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
114
1.14
0.11
5.8
4.3
—
—
—
0
0
(4010399)
30
322
0.93
0.11
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
49
465
1.06
0.11
1.6
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
106
1.13
0.09
1.0
1.1
u/ml
0.2
2.7
—
5
42
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
106
1.13
0.09
1.6
2.4
ug/min
96.1
145.4
—
5
64
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
25
267
0.93
0.08
1.6
2.5
u/ml
31.2
56.4
0.68
25
255
(3009542) Hematocrit [Volume Fraction] of Blood
451
4479
1.03
0.08
21.3
13.2
%
39.8
40.3
0.64
347
3459
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
80
0.87
0.07
1.4
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
84
0.83
0.07
1.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
197
1.07
0.06
1.3
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
537
5351
1.04
0.05
30.9
18.2
e9/l
258.3
254.1
0.74
532
5241
(1002224) Polysomnography panel
23
219
1.05
0.04
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
537
5355
1.03
0.03
30.8
18.2
e12/l
4.5
4.5
1.95
530
5227
(36660697) Celiac disease serology panel - Serum
38
389
0.97
0.02
1.3
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
537
5356
1.02
0.02
30.9
18.2
e9/l
7.1
6.7
2.79
531
5225
(3023511) Choriogonadotropin [Units/volume] in Urine
14
147
0.95
0.01
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
57
562
1.01
0.01
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
10
94
1.06
0.00
1.0
1.0
u/ml
15.0
6.6
—
5
49
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
164
1.04
0.00
2.0
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
107
1071
1.00
0.00
4.8
4.4
ug/l
4.3
2.3
0.42
102
961
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
95
1.05
0.00
1.8
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
214
0.98
0.00
2.7
2.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
144
0.97
0.00
2.8
2.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
60
1.00
0.00
1.5
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
9.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
16.2
—
0
6
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
11.3
—
0
5
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.8
—
5.4
—
0
5
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
3.4
—
0.6
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
9.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
59.2
—
0
6
(4015189)
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.5
—
0.3
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
89
1.01
0.00
1.6
1.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
9.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_MENINGOTH and mortality.

Females

Parameter HR [95% CI] p-value
G6_MENINGOTH 2.298 [1.88, 2.8] < 0.001
Birth year 0.993 [0.98, 1.0] 0.112

During the follow-up period (1.1.1998 — 31.12.2019), 318 out of 1695 females with G6_MENINGOTH died.

Males

Parameter HR [95% CI] p-value
G6_MENINGOTH 2.392 [1.93, 2.96] < 0.001
Birth year 0.988 [0.98, 1.0] 0.026

During the follow-up period (1.1.1998 — 31.12.2019), 335 out of 1631 males with G6_MENINGOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_MENINGOTH.

N-year risk Females Males
1 0.192% 0.399%
5 1.228% 2.535%
10 3.051% 6.679%
15 5.931% 12.873%
20 10.511% 21.46%

Relationships between endpoints

Index endpoint: G6_MENINGOTH – Other meningitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data